Prometheus Biosciences In...

NASDAQ: RXDX · Real-Time Price · USD
199.92
0.18 (0.09%)
At close: Jun 15, 2023, 8:00 PM

Prometheus Biosciences Statistics

Share Statistics

Prometheus Biosciences has 47.81M shares outstanding. The number of shares has increased by 0% in one year.

47.81M
0%
0%
n/a
n/a
43
n/a

Short Selling Information

n/a
n/a
n/a
n/a

Valuation Ratios

The PE ratio is -31.52 and the forward PE ratio is null. Prometheus Biosciences's PEG ratio is -1.46.

-31.52
n/a
656.18
n/a
6.61
-35.47
-1.46
Financial Ratio History

Enterprise Valuation

Prometheus Biosciences has an Enterprise Value (EV) of 4.21B.

617.57
-28.85
-34.12
-33.38

Financial Position

The company has a current ratio of 31.04, with a Debt / Equity ratio of 0.04.

31.04
31.08
0.04
-0.2
-0.23
0

Financial Efficiency

Return on Equity is -20.97% and Return on Invested Capital is -20.57%.

-20.97%
-19.14%
-20.57%
$70,195.88
$-1,461,360.82
97
0.01
n/a

Taxes

-629K
0.44%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is -0.49, so Prometheus Biosciences's price volatility has been lower than the market average.

-0.49
n/a
184.19
109.6
84.04
1,217,911

Income Statement

In the last 12 months, Prometheus Biosciences had revenue of 6.81M and earned -141.75M in profits. Earnings per share was -3.49.

6.81M
6.81M
-145.78M
-141.75M
-145.78M
n/a
-3.49
Full Income Statement

Balance Sheet

The company has 292.42M in cash and 29.54M in debt, giving a net cash position of 262.88M.

292.42M
29.54M
262.88M
-331.09M
758.41M
707.06M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -123.25M and capital expenditures -2.7M, giving a free cash flow of -125.96M.

-123.25M
-2.7M
-125.96M
-3.1
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -2140.96% and -2081.83%.

100%
-2140.96%
-2081.83%
-2081.83%
-2140.96%
-2140.96%
-1849.86%

Dividends & Yields

RXDX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
-3.17%
-2.82%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for RXDX.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

94.06
2